Skip to main content
Back

Recap of Adenylate Cyclase GPCR Signaling definitions

Control buttons has been changed to "navigation" mode.
1/15
  • Adenylate Cyclase

    Effector enzyme regulated by G proteins, catalyzing ATP conversion to cAMP, central to cellular signaling pathways.
  • GPCR

    Membrane receptor that undergoes conformational change upon ligand binding, initiating G protein activation.
  • G Protein

    Heterotrimeric complex mediating signal transduction by exchanging GDP for GTP, influencing effector enzymes.
  • cAMP

    Secondary messenger produced from ATP, allosterically activates protein kinase A to propagate cellular responses.
  • Protein Kinase A

    Heterotetrameric enzyme activated by cAMP, phosphorylates target proteins to modulate cell activity.
  • Phosphatase

    Enzyme reversing phosphorylation by removing phosphate groups, contributing to signal termination.
  • cAMP Phosphodiesterase

    Enzyme converting cAMP to AMP, reducing cAMP levels and aiding in signal termination.
  • Beta Adrenergic Receptor

    GPCR subtype binding epinephrine, triggers stimulatory signaling via G protein activation.
  • Beta Adrenergic Receptor Kinase

    Protein phosphorylating beta adrenergic GPCR, facilitating desensitization of receptor signaling.
  • Beta Arrestin

    Protein binding phosphorylated GPCR, mediates desensitization and inhibits further signaling.
  • Cholera Toxin

    Bacterial toxin inhibiting GTP hydrolysis in stimulatory G proteins, causing persistent adenylate cyclase activation.
  • Pertussis Toxin

    Bacterial toxin disrupting GDP-GTP exchange in inhibitory G proteins, leading to unregulated adenylate cyclase activity.
  • Allosteric Regulation

    Modulation of enzyme activity through binding at sites other than the active site, crucial for signal transduction.
  • Signal Transduction

    Process by which extracellular signals are converted into cellular responses via molecular cascades.
  • AMP

    Non-cyclic product formed from cAMP by phosphodiesterase, marking the end of secondary messenger activity.